Document:

Exhibit 10.2

    
      
        

      

      Exhibit
        10.2

    FORM
      OF

    INTERNAP
      NETWORK SERVICES CORPORATION 

    AMENDED
      AND RESTATED 2005 INCENTIVE STOCK PLAN 

     

    NON-ISO

    STOCK
      OPTION CERTIFICATE

     

    1.    Grant
      of Option.    Internap
      Network Services Corporation, a Delaware corporation (the “Company”),
      hereby grants to Optionee (“Optionee”)
      named
      in the Notice of Grant of Stock Option (the “Notice”),
      an
      option (the “Option”)
      to
      purchase a total number of shares of Stock (the “Shares”)
      set
      forth in the Notice, at the exercise price per share (the “Exercise
      Price”)
      set
      forth in the Notice, subject to the terms, definitions and provisions of the
      Internap Network Services Corporation Amended and Restated 2005 Incentive Stock
      Plan (the “Plan”),
      which
      is incorporated herein by reference, and the terms of this Stock Option
      Certificate (the “Certificate”).
      Unless otherwise defined herein, the terms defined in the Plan shall have the
      same defined meanings in this Certificate. In the event of a conflict between
      the terms and conditions of the Plan and the terms and conditions of this
      Certificate, the terms and conditions of the Plan shall prevail. This option
      is
      a Non-ISO. 

     

    2.    Exercise
      of Option.    This
      Option shall be exercisable during its term in accordance with the vesting
      schedule set out in the Notice so long as Optionee is an Eligible Employee
      or a
      Director, as the case may be, and with the provisions of Section 7.5(b) of
      the
      Plan as set forth below. A change in status of Optionee from his or her status
      at the time of grant (i.e., (i) Optionee is a Director at the time of grant
      and
      subsequently becomes an Eligible Employee or (ii) Optionee is an Eligible
      Employee at the time of grant and subsequently becomes a Director) shall be
      deemed a termination of employment or service with the Company at the time
      of
      such change in status whereupon, unless otherwise provided by the Committee
      in
      its sole discretion, vesting of the Shares shall immediately cease in full.
      

     

    (a)    Right
      to Exercise.
      

     

    (i)    This
      Option may not be exercised for a fraction of a Share. 

     

    (ii)    In
      the event of Optionee’s death, disability or other termination of employment or
      service with the Company, the exercisability of the Option is governed by
      Sections 5, 6, and 7 below, subject to the limitation contained in subsection
      2(a)(i). 

     

    (iii)    In
      no event may this Option be exercised after the date of expiration of the term
      of this Option as set forth in the Notice. 

     

    (b)    Method
      of Exercise.
      

     

    (i)    This
      Option shall be exercisable by (i) delivery of a written notice (in the form
      attached hereto as Exhibit A) which shall state the election to exercise the
      Option, the number of Shares in respect of which the Option is being exercised
      (the “Exercised
      Shares”),
      and
      such other representations and agreements as may be required by the Company
      pursuant to the provisions of the Plan or (ii) by executing a “cashless
      exercise” through the Company’s designated broker. The written notice shall be
      signed by Optionee and shall be delivered in person or by certified mail to
      the
      stock administrator of the Company and shall be accompanied by payment of the
      aggregate Exercise Price as to all Exercised Shares. This Option shall be deemed
      to be exercised upon receipt by the Company of such written notice accompanied
      by such aggregate Exercise Price or by Optionee’s execution of a “cashless”
exercise with the Company’s designated broker. 

     

    (ii)    As
      a condition to the exercise of this Option, Optionee agrees to make adequate
      provision for federal, state or other tax withholding obligations, if any,
      which
      arise upon the exercise of the Option or disposition of Shares, whether by
      withholding, direct payment to the Company, or otherwise. 

     

    (iii)    No
      Shares will be issued pursuant to the exercise of the Option unless such
      issuance and such exercise shall comply with all relevant provisions of
      Applicable Laws. Assuming such compliance, for income tax purposes the Exercised
      Shares shall be considered transferred to Optionee on the date on which the
      Option is exercised with respect to such Exercised Shares. 

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    3.    Method
      of Payment.    Payment
      of the Exercise Price shall be by any of the following, or a combination
      thereof, at the election of Optionee: 

     

    (i)    cash;
      

     

    (ii)    check;
      

     

    (iii)    surrender
      of other Shares which (A) in the case of Shares acquired pursuant to the
      exercise of a Company option, have been owned by Optionee for more than six
      (6)
      months on the date of surrender or were not acquired, directly or indirectly,
      from the Company, and (B) have a Fair Market Value on the date of surrender
      equal to the aggregate Exercise Price of the Shares as to which the Option
      is
      being exercised; or 

     

    (iv)    delivery
      of a properly executed exercise notice together with such other documentation
      as
      the Committee and the broker, if applicable, shall require to effect an exercise
      of the Option and delivery to the Company of the sale or loan proceeds required
      to pay the aggregate Exercise Price. 

     

    4.    Restrictions
      on Exercise.    This
      Option may not be exercised if the issuance of such Shares upon such exercise
      or
      the method of payment of consideration for such Shares would constitute a
      violation of any applicable laws. 

     

    5.    Termination
      of Relationship.    In
      the event of termination of Optionee’s employment or service with the Company,
      Optionee may, but only within three months from the date of such termination
      (but in no event later than the expiration date of the term of such Option
      as
      set forth in Section 9 below), exercise the Option to the extent otherwise
      entitled to exercise it at the date of such termination. To the extent that
      Optionee was not entitled to exercise this Option at the date of such
      termination, or if Optionee does not exercise this Option within the time
      specified herein, the Option shall terminate. A change in status of Optionee
      from his or her status at the time of grant (i.e., (i) Optionee is a Director
      at
      the time of grant and subsequently becomes an Eligible Employee or (ii) Optionee
      is an Eligible Employee at the time of grant and subsequently becomes a
      Director) shall be deemed a termination of employment or service with the
      Company at the time of such change in status whereupon, unless otherwise
      provided by the Committee in its sole discretion, the provisions of this Section
      5 shall apply. 

     

    6.    Disability
      of Optionee.    Notwithstanding
      the provisions of Section 5 above, in the event of termination of Optionee’s
      employment or service with the Company as a result of Optionee’s disability (as
      defined in Section 22(e) of the Internal Revenue Code), Optionee may, but only
      within twelve (12) months from the date of such termination (but in no event
      later than the expiration date of the term of such Option as set forth in
      Section 9 below), exercise the Option to the extent otherwise entitled to
      exercise it at the date of such termination. To the extent that Optionee was
      not
      entitled to exercise this Option at the date of such termination, or if Optionee
      does not exercise this Option within the time specified herein, the Option
      shall
      terminate. 

     

    7.    Death
      of Optionee.    In
      the event of the death of Optionee, the Option may be exercised at any time
      within twelve (12) months following the date of Optionee’s death (but in no
      event later than the date of expiration of the term of this Option as set forth
      in Section 9 below), by Optionee’s estate, by a person who acquired the right to
      exercise the Option by bequest or inheritance or by the laws of descent and
      distribution or by a beneficiary designated to exercise the Option upon the
      Optionee’s death pursuant to Section 8, but only to the extent Optionee could
      exercise the Option at the date of death. To the extent that Optionee was not
      entitled to exercise this Option at the date of such termination, or if
      Optionee’s estate, the person who acquired the right to exercise the Option by
      bequest or inheritance or by the laws of descent and distribution or the
      beneficiary designated to exercise the Option upon the Optionee’s death pursuant
      to Section 8 does not exercise this Option within the time specified herein,
      the
      Option shall terminate. 

     

    8.    Non-Transferability
      of Option.    This
      Option may not be transferred in any manner otherwise than by will or by the
      laws of descent or distribution and may be exercised during the lifetime of
      Optionee only by Optionee. Notwithstanding the foregoing, the Optionee may,
      by
      delivering written notice to the Company, in a form satisfactory to the Company,
      designate a beneficiary who, in the event of the death of the Optionee, shall
      thereafter be entitled to exercise the Option. The terms of this Option shall
      be
      binding upon the executors, administrators, heirs, successors and assigns of
      Optionee. 

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    9.    Term
      of Option.    This
      Option may be exercised only within the term set out in the Notice, and may
      be
      exercised during such term only in accordance with the Plan and the terms of
      this Certificate. 

     

    10.    Tax
      Consequences.    Set
      forth below is a brief summary as of the date of this Option of certain United
      States federal tax consequences of exercise of this Option and disposition
      of
      the Shares under the laws in effect as of the date of grant. THIS
      SUMMARY DOES NOT ADDRESS SPECIFIC STATE, LOCAL OR FOREIGN TAX CONSEQUENCES
      THAT
      MAY BE APPLICABLE TO OPTIONEE. OPTIONEE IS RESPONSIBLE FOR CONSULTING A TAX
      ADVISER AS TO THE APPLICABLE TAX
      LAWS OF THE JURISDICTION(S) IN WHICH OPTIONEE RESIDES OR MAY BE SUBJECT TO
      TAX
      BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES. OPTIONEE UNDERSTANDS
      THAT THIS SUMMARY IS NECESSARILY INCOMPLETE, AND THE TAX LAWS AND REGULATIONS
      ARE SUBJECT TO CHANGE. 

     

    (i)    Exercise
      of Non-ISO.    There
      may be a regular federal income tax liability upon the exercise of the Option.
      Optionee will be treated as having received compensation income (taxable at
      ordinary income tax rates) equal to the excess, if any, of the Fair Market
      Value
      of the Shares on the date of exercise over the Exercise Price. If Optionee
      is an
      employee or former employee of the Company, the Company will be required to
      withhold from Optionee’s compensation or collect from Optionee and pay to the
      applicable taxing authorities an amount equal to a percentage of this
      compensation income at the time of exercise. 

     

    (ii)    Disposition
      of Shares.    In
      the case of a Non-ISO, if Shares are held for more than one year after the
      date
      of exercise, any gain realized on disposition of the Shares will be treated
      as
      long-term capital gain for federal income tax purposes. 

     

    11.    Governing
      Law.    This
      Certificate shall be governed by and construed according to the laws of the
      State of Delaware without regard to its principles of conflict of laws.

     

    12.    Whole
      Certificate.    The
      Plan and Notice are hereby incorporated by reference and made a part hereof,
      and
      the Option and this Certificate shall be subject to all terms and conditions
      of
      the Plan and the Notice. 

     

    13.    Amendments.    This
      Certificate may be amended or modified at any time only by an instrument in
      writing signed by each of the parties hereto. 

     

    14.    Rights
      as a Stockholder.    Neither
      Optionee nor any of Optionee’s successors in interest shall have any rights as a
      stockholder of the Company with respect to any Shares subject to the Option
      until the date of issuance of a stock certificate for such Shares or the date
      the Shares are electronically delivered to Optionee’s brokerage account.Amendment and Consent to Release dated August 2, 2006

 Exhibit 10.1 
 AMENDMENT AND CONSENT TO RELEASE 
 This Amendment and Consent to Release (this “Amendment”), dated
as of August 2, 2006, among Biovest International, Inc. a Delaware corporation (“Biovest” or, the “Company”), Biovax, Inc., a Florida corporation and a wholly-owned subsidiary of the Company
(“Biovax” and, together with the Company, the “Credit Parties” and each, a “Credit Party”) and Laurus Master Fund, Ltd., a Cayman Islands company (“Laurus”) amends (x) that
certain Restricted Account Side Letter, dated as of March 31, 2006 by and between the Company and Laurus (as amended, modified or supplemented from time to time, the “Side Letter Agreement”), which is entered into in connection
with that certain Restricted Account Agreement dated as of March 31, 2006, among the Company, North Fork Bank and Laurus (as amended, modified or supplemented from time to time, the “Restricted Account Agreement”) and
(y) that certain Secured Promissory Note, issued in the initial face amount of $7,799,000 by the Company to Laurus as of March 31, 2006 (as amended, modified or supplemented from time to time, the “Note”). Capitalized
terms used herein but not otherwise defined herein shall have the meanings ascribed to such terms in that certain (x) Note and Warrant Purchase Agreement, dated as of March 31, 2006, by and between the Company and Laurus (as amended,
modified or supplemented from time to time, the “Note Purchase Agreement”) and (y) the Side Letter Agreement, as applicable. The parties hereto acknowledge and agree that this Amendment shall constitute a “Related
Agreement” as defined in the Note Purchase Agreement. 
 WHEREAS, the Company has advised Laurus that it has an opportunity to
potentially enhance its planned New Markets Tax Credit financing based on an allocation of New Market Tax Credits from the City of St Louis due to potential involvement of agencies of the State of Missouri but such potential involvement will require
a delay in the closing of the planned financing and satisfaction of the preconditions to release of funds from the Restricted Account (as defined in the Restricted Account Agreement); and 
 WHEREAS, the Company has requested that Laurus agree to release to the Company the sum of $2,500,000 prior to the satisfaction of the preconditions for
such release as set forth in the Side Letter Agreement; and 
 NOW, THEREFORE, in consideration of the above, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 
 1. Consent to
Release. Upon the occurrence of the Amendment Effective Date, Laurus hereby agrees, notwithstanding the terms and conditions of the Side Letter Agreement, to direct North Fork Bank to release (the “Release”) the sum of
$2,500,000 from the Restricted Account to the Company per the wiring instructions attached hereto as Exhibit A. 
 2. Additional
Agreements. In consideration of the Release, the Company hereby covenants and agrees for the benefit of Laurus that (x) on or before September 15, 2006: (i) the Company and/or any of its wholly-owned Subsidiaries shall have
consummated a New Market Tax Credit “NMTC” program (not including New Market Tax Credit “NMTC” programs consummated prior to the date hereof), (ii) the Company and/or any of its wholly-owned Subsidiaries shall have received
NMTC Qualifying Net Proceeds of no less than $7,500,000 from the consummation of such New Market Tax Credit “NMTC” program referred to in clause (i) above, (iii) of the $7,500,000 of NMTC Qualifying Net Proceeds required to be
received by the Company and/or its wholly-owned Subsidiaries per clause (ii) above, the Company alone shall have received no less than $4,000,000 of such NMTC Qualifying Net Proceeds (whether in partial payment of its $9,900,000 certifiable
cost basis in the development of AutoVaxID TM or
otherwise), and (iv) no more than $1,000,000 of the net proceeds of the Release shall be used to repay 

 intercompany debt owing by the Company to Accentia Biopharmaceuticals, Inc., and (y) the Company shall provide
Laurus with written notice within one (1) Business Day of the date upon which the Company first becomes aware that any of the requirements set forth above may not be achieved within the time frames provided herein. The Company acknowledges and
agrees that, notwithstanding anything to the contrary set forth in Section 3.1(k)(ii) of the Note, if any of the requirements and covenants set forth above in this Section 2 are not satisfied in full within the time periods provided above,
such failure shall, upon provision by Laurus of written notice to the Company, constitute and give rise to an immediate Event of Default under the Note. 
 3. Effectiveness. This Amendment shall be effective as of the date first above written (the “Amendment Effective Date”) when each Credit Party and Laurus shall have executed and each Credit
Party shall have delivered to Laurus their respective counterpart signatures to this Amendment. 
 4. Representation. Each Credit
Party hereby represents and warrants to Laurus that (i) no Event of Default exists on the date hereof, (ii) on the date hereof, all representations, warranties and covenants made by the Credit Parties in connection with the Note Purchase
Agreement and the Related Agreements referred to therein (collectively, the “Funding Documents”) are true, correct and complete and (iii) on the date hereof, all of the Company’s and its Subsidiaries’ covenant
requirements have been met. 
 5. References. From and after the Amendment Effective Date, all references in the Funding Documents
shall be deemed to be references to the Funding Documents as modified hereby. This Amendment shall be deemed a Related Agreement as defined in the Note Purchase Agreement. 
 6. No other Changes. Except as expressly set forth in this Amendment no other term or provision of any Funding Document is hereby amended or
affected in any way and the Funding Documents shall remain in full force and effect after the date hereof. 
 7. Public Disclosure.
The Company understands that it has an affirmative obligation to make prompt public disclosure of material agreements and material amendments to such agreements. It is the Company’s determination that neither this Amendment nor the terms and
provisions of this Amendment (collectively, the “Information”) are material. The Company has had an opportunity to consult with counsel concerning this determination. The Company hereby agrees that Laurus shall not be in violation
of any duty to the Company or its shareholders, nor shall Laurus be deemed to be misappropriating any information of the Company, if Laurus sells shares of common stock of the Company, or otherwise engages in transactions with respect to securities
of the Company, while in possession of the Information. 
 8. Miscellaneous. This Amendment shall be binding upon the parties hereto
and their respective successors and assigns and shall inure to the benefit of and be enforceable by each of the parties hereto and its successors and permitted assigns. THIS AMENDMENT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH AND
GOVERNED BY THE LAW OF THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. This Amendment shall be executed in any number of counterparts, each of which shall be an original, but all of which shall constitute one
instrument. 
 [THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 
  

 2 

 IN WITNESS WHEREOF, each of the undersigned has caused this Amendment to be duly executed as of the date first
above written. 
  

			
	BIOVEST INTERNATIONAL, INC.
		
	By:	 	 /s/ Steve Arikian

	Name:	 	Steve Arikian
	Title:	 	Chairman & CEO
	
	BIOVAX, INC.
		
	By:	 	 /s/ Steve Arikian

	Name:	 	Steve Arikian
	Title:	 	Chairman & CEO
	
	LAURUS MASTER FUND, LTD.
		
	By:	 	 /s/ Eugene Grin

	Name:	 	Eugene Grin
	Title:	 	Director

  

 3 

 EXHIBIT A 
 WIRING INSTRUCTIONS 
 Biovest International, Inc. 
 Wachovia Bank, NA 
 ABA 063000021

 Acct# 2000028686679 
  

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]